Plasma exchange, intravenous immunoglobulin and corticosteroids continue to be the mainstay of treatment for inflammatory neuropathies. Recent trials demonstrate that combining these therapies is not significantly more effective than single agent treatment. The usefulness of novel immunotherapies and cytotoxic agents is difficult to ascertain because of the treatment of small numbers of patients in open-label studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1471-4892(02)00158-3 | DOI Listing |
Publication Analysis
Top Keywords
immunosuppression peripheral
4
peripheral neuropathy
4
neuropathy rationale
4
rationale reality
4
reality plasma
4
plasma exchange
4
exchange intravenous
4
intravenous immunoglobulin
4
immunoglobulin corticosteroids
4
corticosteroids continue
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!